URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Michelle Janelsins

Concepts (112)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Breast Neoplasms
6
2010
675
1.440
Why?
Antineoplastic Agents
5
2009
625
1.300
Why?
Cognition Disorders
2
2011
278
1.230
Why?
Neoplasms
7
2009
723
1.180
Why?
Tai Ji
3
2010
22
1.010
Why?
Survivors
5
2009
114
0.860
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2011
430
0.740
Why?
Dentate Gyrus
1
2010
26
0.740
Why?
Insulin-Like Growth Factor I
1
2010
106
0.690
Why?
Blood-Brain Barrier
1
2010
108
0.690
Why?
Gene Expression Regulation, Neoplastic
1
2011
254
0.670
Why?
Alzheimer Disease
2
2008
289
0.630
Why?
Insulin
1
2011
670
0.620
Why?
Cytokines
1
2011
572
0.590
Why?
Inflammation
1
2008
550
0.480
Why?
Neurons
2
2008
1108
0.470
Why?
Tumor Necrosis Factor-alpha
1
2008
695
0.470
Why?
Exercise
2
2009
182
0.330
Why?
Quality of Life
3
2009
509
0.320
Why?
Humans
16
2008
36400
0.290
Why?
Female
11
2009
19826
0.270
Why?
Aged
7
2009
7272
0.260
Why?
Middle Aged
8
2009
9877
0.260
Why?
Geriatric Assessment
2
2011
150
0.220
Why?
Boronic Acids
1
2012
31
0.210
Why?
Antibodies, Monoclonal, Humanized
1
2012
89
0.210
Why?
Pyrazines
1
2012
35
0.210
Why?
Multiple Myeloma
1
2012
76
0.200
Why?
Double-Blind Method
2
2010
998
0.200
Why?
Adult
5
2010
11345
0.190
Why?
Antineoplastic Agents, Hormonal
1
2011
46
0.190
Why?
National Institutes of Health (U.S.)
1
2011
63
0.190
Why?
Brain
2
2008
1221
0.190
Why?
Benzhydryl Compounds
1
2010
13
0.190
Why?
Interleukin-8
1
2011
111
0.190
Why?
Resistance Training
1
2010
7
0.190
Why?
Bone Density Conservation Agents
1
2011
51
0.190
Why?
tau Proteins
2
2008
94
0.190
Why?
Bromodeoxyuridine
1
2010
67
0.180
Why?
Vitamin D
1
2011
70
0.180
Why?
Central Nervous System Stimulants
1
2010
42
0.180
Why?
Neurogenesis
1
2010
30
0.180
Why?
Chemokine CCL2
1
2011
128
0.180
Why?
Radiation Injuries
1
2011
130
0.180
Why?
Fluorouracil
1
2010
76
0.180
Why?
Paclitaxel
1
2010
57
0.180
Why?
Cyclophosphamide
1
2010
173
0.180
Why?
Doxorubicin
1
2010
109
0.180
Why?
Weight Loss
1
2010
75
0.180
Why?
Aged, 80 and over
3
2010
2513
0.180
Why?
Pilot Projects
1
2011
441
0.170
Why?
Medicare
1
2011
130
0.170
Why?
Tumor Markers, Biological
1
2011
228
0.170
Why?
Mice
3
2008
6103
0.170
Why?
Plaque, Amyloid
1
2009
3
0.170
Why?
Tauopathies
1
2009
5
0.170
Why?
Sleep Initiation and Maintenance Disorders
1
2009
45
0.170
Why?
Mice, Transgenic
2
2008
769
0.170
Why?
Biomedical Research
1
2011
140
0.170
Why?
Fatigue
1
2010
125
0.170
Why?
Transgenes
1
2008
74
0.160
Why?
Analysis of Variance
1
2011
725
0.160
Why?
Interleukin-6
1
2011
340
0.160
Why?
Amyloid beta-Peptides
1
2008
56
0.160
Why?
Dependovirus
1
2008
69
0.160
Why?
Myelin Sheath
1
2009
81
0.160
Why?
Microglia
1
2008
80
0.160
Why?
Brain Neoplasms
1
2011
282
0.160
Why?
Mice, Inbred C57BL
2
2009
1683
0.150
Why?
Smoking
1
2011
390
0.150
Why?
Bone and Bones
1
2010
357
0.140
Why?
Macrophages
1
2008
347
0.140
Why?
Genetic Vectors
1
2008
339
0.140
Why?
Cell Proliferation
1
2010
521
0.140
Why?
Male
7
2009
19713
0.130
Why?
Prostatic Neoplasms
1
2011
556
0.130
Why?
Aging
1
2011
706
0.120
Why?
Risk Factors
1
2011
2318
0.120
Why?
Animals
3
2008
16270
0.120
Why?
Time Factors
1
2011
3201
0.120
Why?
Age Factors
3
2009
1121
0.100
Why?
Osteoporosis
2
2010
85
0.090
Why?
Prevalence
2
2009
541
0.080
Why?
United States
2
2011
2630
0.060
Why?
Nutrition Disorders
1
2011
17
0.050
Why?
Hearing Disorders
1
2011
25
0.050
Why?
Organizational Innovation
1
2011
28
0.050
Why?
Accidental Falls
1
2011
43
0.050
Why?
Urinary Incontinence
1
2011
46
0.050
Why?
Vitamin D Deficiency
1
2011
35
0.050
Why?
Syndrome
1
2011
210
0.050
Why?
Memory Disorders
1
2011
48
0.050
Why?
Vision Disorders
1
2011
70
0.050
Why?
Neoplasm Staging
1
2011
335
0.050
Why?
Bone Density
1
2011
115
0.050
Why?
Collagen Type I
1
2010
52
0.050
Why?
Placebos
1
2010
182
0.050
Why?
Feasibility Studies
1
2010
205
0.040
Why?
Comorbidity
1
2011
374
0.040
Why?
Health Status
1
2011
269
0.040
Why?
Survival Rate
1
2011
619
0.040
Why?
Nerve Fibers, Myelinated
1
2009
38
0.040
Why?
Continental Population Groups
1
2009
117
0.040
Why?
Logistic Models
1
2011
578
0.040
Why?
Prognosis
1
2011
1080
0.040
Why?
Peptides
1
2010
288
0.040
Why?
Bone Resorption
1
2010
243
0.040
Why?
Sex Factors
1
2009
584
0.040
Why?
Biological Markers
1
2010
564
0.040
Why?
Depression
1
2011
431
0.030
Why?
Retrospective Studies
1
2011
2260
0.030
Why?
Adolescent
1
2010
4752
0.020
Why?

Visualizations


Janelsins's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department